Ostrum Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.16M | Sell |
28,474
-6,879
| -19% | -$763K | 0.15% | 127 |
|
2025
Q1 | $3.96M | Sell |
35,353
-777
| -2% | -$87.1K | 0.21% | 89 |
|
2024
Q4 | $3.34M | Sell |
36,130
-10,934
| -23% | -$1.01M | 0.29% | 89 |
|
2024
Q3 | $3.95M | Sell |
47,064
-17,275
| -27% | -$1.45M | 0.33% | 72 |
|
2024
Q2 | $4.41M | Sell |
64,339
-10,193
| -14% | -$699K | 0.39% | 53 |
|
2024
Q1 | $5.46M | Sell |
74,532
-1,326
| -2% | -$97.1K | 0.43% | 41 |
|
2023
Q4 | $6.15M | Buy |
75,858
+10,627
| +16% | +$861K | 0.53% | 31 |
|
2023
Q3 | $4.89M | Sell |
65,231
-12,679
| -16% | -$950K | 0.45% | 44 |
|
2023
Q2 | $6M | Sell |
77,910
-7,875
| -9% | -$607K | 0.5% | 36 |
|
2023
Q1 | $7.12M | Buy |
+85,785
| New | +$7.12M | 0.62% | 17 |
|
2019
Q1 | – | Sell |
-11,945
| Closed | -$747K | – | 148 |
|
2018
Q4 | $747K | Buy |
+11,945
| New | +$747K | 0.29% | 104 |
|